Viveve Medical (VIVE) Competitors $0.0002 0.00 (0.00%) As of 03:39 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsSEC FilingsTrendsBuy This Stock VIVE vs. NMRD, BRSH, UTRS, MOTS, DRTSW, ANZUW, IONM, ATAKW, BBLGW, and BRSHWShould you be buying Viveve Medical stock or one of its competitors? The main competitors of Viveve Medical include Nemaura Medical (NMRD), Bruush Oral Care (BRSH), Minerva Surgical (UTRS), Motus GI (MOTS), Alpha Tau Medical (DRTSW), Anzu Special Acquisition Corp I (ANZUW), Assure (IONM), Aurora Technology Acquisition (ATAKW), Bone Biologics (BBLGW), and Bruush Oral Care (BRSHW). These companies are all part of the "medical equipment" industry. Viveve Medical vs. Nemaura Medical Bruush Oral Care Minerva Surgical Motus GI Alpha Tau Medical Anzu Special Acquisition Corp I Assure Aurora Technology Acquisition Bone Biologics Bruush Oral Care Nemaura Medical (NASDAQ:NMRD) and Viveve Medical (NASDAQ:VIVE) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, valuation, risk, analyst recommendations, institutional ownership, earnings, community ranking, profitability and media sentiment. Does the MarketBeat Community believe in NMRD or VIVE? Viveve Medical received 307 more outperform votes than Nemaura Medical when rated by MarketBeat users. Likewise, 73.70% of users gave Viveve Medical an outperform vote while only 57.14% of users gave Nemaura Medical an outperform vote. CompanyUnderperformOutperformNemaura MedicalOutperform Votes457.14% Underperform Votes342.86% Viveve MedicalOutperform Votes31173.70% Underperform Votes11126.30% Which has more volatility & risk, NMRD or VIVE? Nemaura Medical has a beta of 0.76, suggesting that its stock price is 24% less volatile than the S&P 500. Comparatively, Viveve Medical has a beta of 1, suggesting that its stock price has a similar volatility profile to the S&P 500. Is NMRD or VIVE more profitable? Company Net Margins Return on Equity Return on Assets Nemaura MedicalN/A N/A N/A Viveve Medical N/A N/A N/A Which has better valuation & earnings, NMRD or VIVE? Viveve Medical has higher revenue and earnings than Nemaura Medical. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNemaura Medical$3.02K2.67-$14.14M-$0.390.00Viveve Medical$6.83M0.00N/AN/AN/A Do institutionals and insiders believe in NMRD or VIVE? 4.4% of Nemaura Medical shares are held by institutional investors. 40.4% of Nemaura Medical shares are held by insiders. Comparatively, 5.7% of Viveve Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Does the media favor NMRD or VIVE? In the previous week, Nemaura Medical's average media sentiment score of 0.00 equaled Viveve Medical'saverage media sentiment score. Company Overall Sentiment Nemaura Medical Neutral Viveve Medical Neutral SummaryViveve Medical beats Nemaura Medical on 4 of the 7 factors compared between the two stocks. Remove Ads Get Viveve Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for VIVE and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VIVE vs. The Competition Export to ExcelMetricViveve MedicalElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$2,000.00$3.31B$5.59B$7.92BDividend YieldN/A1.64%5.35%4.04%P/E RatioN/A15.5423.6618.81Price / Sales0.0042.86369.2188.69Price / CashN/A44.0938.1634.64Price / BookN/A3.426.714.18Net IncomeN/A$94.03M$3.20B$247.10M7 Day PerformanceN/A-0.90%-3.93%-2.96%1 Month PerformanceN/A-11.09%-0.55%-6.48%1 Year PerformanceN/A-20.08%9.21%0.23% Viveve Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VIVEViveve MedicalN/A$0.00flatN/A+0.0%$2,000.00$6.83M0.0070High Trading VolumeNMRDNemaura MedicalN/A$0.00flatN/AN/A$8,000.00$3,017.000.0040BRSHBruush Oral CareN/A$0.00flatN/A-98.1%$1,000.00$2.92M0.0011Positive NewsUTRSMinerva SurgicalN/AN/AN/AN/A$1,000.00$51.69M0.00160MOTSMotus GIN/AN/AN/A-100.0%$1,000.00$319,000.000.0030DRTSWAlpha Tau MedicalN/A$0.22-3.8%N/A-12.0%$0.00N/A0.0080Gap DownANZUWAnzu Special Acquisition Corp IN/A$0.03+6.8%N/A-69.0%$0.00N/A0.002Gap UpIONMAssureN/AN/AN/AN/A$0.00$149,000.000.00130ATAKWAurora Technology AcquisitionN/A$0.01-34.6%N/A+26.7%$0.00N/A0.00N/ABBLGWBone BiologicsN/A$20.20-2.9%N/A+17.4%$0.00N/A0.002Gap UpBRSHWBruush Oral CareN/AN/AN/AN/A$0.00$2.92M0.0011 Remove Ads Related Companies and Tools Related Companies Nemaura Medical Competitors Bruush Oral Care Competitors Minerva Surgical Competitors Motus GI Competitors Alpha Tau Medical Competitors Anzu Special Acquisition Corp I Competitors Assure Competitors Aurora Technology Acquisition Competitors Bone Biologics Competitors Bruush Oral Care Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:VIVE) was last updated on 4/2/2025 by MarketBeat.com Staff From Our PartnersTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredMost gold “analysts” aren’t really gold analysts… [watch out]People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | Sponsored10X Bigger than AI, quantum, EVs, crypto, and robotics combined?World Economic Forum: "Arguably the Most Exciting Human Discovery Since Fire" Sam Altman, Bill Gates, and M...Stansberry Research | SponsoredDOGE tax surpriseElon Musk's DOGE agents have some very strange plans for the IRS... Recently, it emerged that our tax auth...Altimetry | SponsoredTrump’s betrayal exposed Fair warning: this will not make for easy viewing. Especially if you voted for Trump, put your faith in hi...Porter & Company | SponsoredNew “Trump” currency proposed in DCYou’ve no doubt heard Trump’s rally cry: Make America Great Again. But recently the President made a big ch...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Viveve Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Viveve Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
